Akebia Therapeutics, Inc.
AKBA
$3.26
$0.0652.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.48M | -45.31M | -69.41M | -45.99M | -40.44M |
| Total Depreciation and Amortization | 23.55M | 32.64M | 41.70M | 41.78M | 41.82M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.05M | 32.11M | 26.73M | 18.36M | 8.86M |
| Change in Net Operating Assets | -35.51M | -54.26M | -39.68M | -52.65M | -49.20M |
| Cash from Operations | -2.40M | -34.81M | -40.66M | -38.50M | -38.97M |
| Capital Expenditure | -148.00K | -51.00K | -33.00K | -31.00K | -29.00K |
| Sale of Property, Plant, and Equipment | 172.00K | 172.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 24.00K | 121.00K | -33.00K | -31.00K | -29.00K |
| Total Debt Issued | 10.00M | 18.00M | 45.00M | 45.00M | 45.00M |
| Total Debt Repaid | -461.00K | -835.00K | -37.10M | -45.10M | -45.10M |
| Issuance of Common Stock | 91.26M | 89.55M | 43.03M | 27.42M | 25.73M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -585.00K | -585.00K | -1.27M | -1.27M | -750.00K |
| Cash from Financing | 100.21M | 106.13M | 49.66M | 26.05M | 24.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.83M | 71.44M | 8.97M | -12.48M | -14.13M |